Quidel Molecular Direct C. difficile

For the qualitive detection and identification of toxigenic Clostridium difficle bacterial DNA using real time PCR

  • <70-minute turn-around time from sample to result.
  • 3-step sample preparation
    • No heat step
    • No timed step
    • No vortexing or centrifugation

Why Test?

  • Nucleic acid amplification tests can be as much as twice as sensitive as enzyme immunoassays.1
  • Increasing rates of commmunity-acquired C. difficile.2
  • C. difficile infection (CDI) can range in severity from asymptomatic to life-threatening, especially among the elderly (most often nosocomially infected in hospitals, nursing homes or other medical institutions).3
  • Relapses of C. difficile have been reported in up to 20% of cases.4 Increases to 40% and 60% with subsequent recurrences.5
  • C. difficile infection often mimics some flu-like symptoms and can mimic disease flare in patients with inflammatory bowel disease associated colitis.6
ORDERING INFORMATION
Catalog Kit Size/Volume Description
M105 96 tests Assay Kit
M207
(required for M105)
96 samples Sample Prep Kit
M108 2 mL Control Kit

Also available through Life Technologies.

1Howell MD, Novack V, Grgurich P et al. Latrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch. Intern. Med. May 2010:170 (9):784-90.
2Clabots CR, Johnson S, Olson MM, Peterson LR, Gering DN. Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J. Infect Dis. Sept 1992:166 (3):561-7.
3Ryan KJ, CG (ed). Sherris Medical Microbiology (4th ed.) McGraw Hill. pp. 322-4.
4Kelly CP, LaMont JT. Clostridium difficile-more difficult than ever. N. Engl. J. Med. Oct 2008:359 (18): 1932-40.


Note: Select multiple products by holding down the CTRL key while clicking on additional products.
*Note: All products may not be available in the U.S.

Fluorescent immunoassay for the differential detection of influenza type A and type B from nasal swab, nasopharyngeal swab (NPS) or nasal wash/aspirate specimens. » more


Allows for the detection of 8 viruses with DFA accuracy in under 25 minutes from specimen receipt to virus detection.
» more